Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre-Stéphane Gsell

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Vaccine|November 10, 2023
Key considerations for the development of novel mRNA candidate vaccines in LMICs: A WHO/MPP mRNA Technology Transfer Programme meeting reportPierre-Stéphane Gsell, Birgitte Giersing, Sami Gottlieb, et al.
Vaccine|January 19, 2020
Meeting report: WHO consultation on accelerating Lassa fever vaccine development in endemic countries, Dakar, 10-11 September 2019Kolawole Salami, Pierre-Stéphane Gsell, Adebola Olayinka, et al.
Science Translational Medicine|July 5, 2019
Design of vaccine efficacy trials during public health emergenciesNatalie E Dean, Pierre-Stéphane Gsell, Ron Brookmeyer, et al.
Vaccine|June 28, 2019
An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-ToolSteven E Bellan, Rosalind M Eggo, Pierre-Stéphane Gsell, et al.
Frontiers in Public Health|November 22, 2021
Electronic Data Management for Vaccine Trials in Low Resource Settings: Upgrades, Scalability, and Impact of ODKMichael Marks, Sham Lal, Hannah Brindle, et al.
American Journal of Epidemiology|April 4, 2019
Determinants of Transmission Risk During the Late Stage of the West African Ebola EpidemicAlexis Robert, W John Edmunds, Conall H Watson, et al.
The New England Journal of Medicine|December 18, 2024
Ebola Outbreak Response in the DRC with rVSV-ZEBOV-GP Ring VaccinationJean-Jacques Muyembe, Hongchao Pan, Richard Peto, et al.
The Lancet. Infectious Diseases|October 17, 2017
Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety reportPierre-Stéphane Gsell, Anton Camacho, Adam J Kucharski, et al.
Virus Evolution|March 17, 2023
Quantifying the value of viral genomics when inferring who infected whom in the 2014-16 Ebola virus outbreak in GuineaAlexis Robert, Joseph Tsui Lok Hei, Conall H Watson, et al.
Lancet (London, England)|December 27, 2016
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)Ana Maria Henao-Restrepo, Anton Camacho, Ira M Longini, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Vaccine|November 10, 2023
Key considerations for the development of novel mRNA candidate vaccines in LMICs: A WHO/MPP mRNA Technology Transfer Programme meeting reportPierre-Stéphane Gsell, Birgitte Giersing, Sami Gottlieb, et al.
Vaccine|January 19, 2020
Meeting report: WHO consultation on accelerating Lassa fever vaccine development in endemic countries, Dakar, 10-11 September 2019Kolawole Salami, Pierre-Stéphane Gsell, Adebola Olayinka, et al.
Science Translational Medicine|July 5, 2019
Design of vaccine efficacy trials during public health emergenciesNatalie E Dean, Pierre-Stéphane Gsell, Ron Brookmeyer, et al.
Vaccine|June 28, 2019
An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-ToolSteven E Bellan, Rosalind M Eggo, Pierre-Stéphane Gsell, et al.
Frontiers in Public Health|November 22, 2021
Electronic Data Management for Vaccine Trials in Low Resource Settings: Upgrades, Scalability, and Impact of ODKMichael Marks, Sham Lal, Hannah Brindle, et al.
American Journal of Epidemiology|April 4, 2019
Determinants of Transmission Risk During the Late Stage of the West African Ebola EpidemicAlexis Robert, W John Edmunds, Conall H Watson, et al.
The New England Journal of Medicine|December 18, 2024
Ebola Outbreak Response in the DRC with rVSV-ZEBOV-GP Ring VaccinationJean-Jacques Muyembe, Hongchao Pan, Richard Peto, et al.
The Lancet. Infectious Diseases|October 17, 2017
Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety reportPierre-Stéphane Gsell, Anton Camacho, Adam J Kucharski, et al.
Virus Evolution|March 17, 2023
Quantifying the value of viral genomics when inferring who infected whom in the 2014-16 Ebola virus outbreak in GuineaAlexis Robert, Joseph Tsui Lok Hei, Conall H Watson, et al.
Lancet (London, England)|December 27, 2016
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)Ana Maria Henao-Restrepo, Anton Camacho, Ira M Longini, et al.
Pageof 2